Vetter Completes Chicago Expansion

Vetter’s U.S. early-stage development site at the Illinois Science and Technology Park in Chicago, has completed its expansion with the addition of a third cleanroom. Clinical syringe projects are now being accepted at the facility, which can handle preclinical through Phase II projects.
 
The overall 30,000-sq.-ft. site offers resources for early-stage clinical manufacturing, including chemical analysis and microbiology labs, material preparation and compounding functions. The addition of the third cleanroom, filling of single-chamber syringes is now available with a maximum filling speed of 3,600 units per hour, and batch sizes as large as 25,000 units. The line is constructed as a Restricted Access Barrier System (RABS), offering various filling pumps, as well as fully automated tub processing.
 
The two existing cleanrooms provide automated vial filling for batches up to 10,000 liquid or lyophilized vials, as well as semi-automated filling for manufacturing prefilled syringes, cartridges, and vials in small batch sizes of a few hundred.
 
Vetter’s managing director Peter Soelkner, said, “The newest cleanroom, which performs clinical manufacturing of syringes, is a demonstration of Vetter’s consistent approach to staying ahead of the market. For many indications, prefilled syringes provide advantages that will become even more important in the future of drug delivery. With our Chicago site, we can now offer our customers filling of this delivery system from early in the drug development process, affording them an innovative approach and an early advantage in today’s highly competitive markets.”